Pharming PHAR
NASDAQ PHAR
$11.54 +0.08 (+0.71%)
As of: Sep 4, 2026 · 2:33 PM EDT

Pharming (PHAR) Total Debt (QoQ) (2021 - 2022)

Analysis

Pharming (PHAR) Total Debt (QoQ) (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Pharming 794.84 Mn 635.34 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 52,534.97%
Sep 30, 2022 -5.92%
Jun 30, 2022 -6.17%
Mar 31, 2022 -2.34%
Dec 31, 2021 -62.30%
Sep 30, 2021 66.83%
Jun 30, 2021 -6.16%
Mar 31, 2021 -26.34%